乳児の発作症候群におけるケトジックダイエットの有効性と安全性:メタ解析
CaoXue Zuo1, KangJie Xu2, Kun Ni3
1Department of Neurology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Clinical Research Center of Neurodevelopmental Disabilities in Children in Hubei Province, Wuhan, China.
Seizure
|September 4, 2025
まとめ
ケトジェニックダイエット (KD) は,乳児性症候群 (IESS) のを効果的に軽減する. このダイエットは 制御可能な副作用で EEGと発育を改善し 薬剤耐性患者のための安全な選択肢です
科学分野:
- 神経学
- 小児神経学
- ダイエット 療法
背景:
- 幼児の症候群 (IESS) は重度の症候群である.
- 治療抵抗はIESSにおいて一般的であり,代替治療戦略が必要である.
研究 の 目的:
- IESSの治療におけるケトジェニックダイエット (KD) の有効性と安全性を体系的に評価する.
- IESS患者におけるKDの予後研究から得られた証拠を統合する.
主な方法:
- 電子データベースの包括的なメタ分析が行われました.
- IESSのKDに関する予後研究が特定され,分析された.
- ランダム効果モデルがデータ合成に使用された.
主要な成果:
- 3~12ヶ月の小児の60~66%において,KDはを≥50%減少させました.
- 3~12ヶ月で発作がなくなるのは19~21%の患者で観察された.
- EEG,運動,認知,言語の発達に顕著な改善が認められた (P < 0. 01).
- 胃腸疾患と内環境障害 (それぞれ32%) が一般的には軽度であった.
結論:
- ケトゲンダイエットは 薬剤耐性IESSの有効で安全な治療法です
- KDは発作のコントロールと 発達上の結果において 重要な利点をもたらします
- 確実性の低い証拠と出版バイアスのために,さらに高品質な研究が必要である.
さらに関連する動画
関連する概念動画
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
439
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
439
01:24Epilepsy and Seizures: Overview
274
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
274
01:20Antiepileptic Drugs: Potassium Channel Activators
272
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
272
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
632
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
632
01:08Antiepileptic Drugs: Sodium Channel Blockers
861
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
861
01:14Antiepileptic Drugs: Glutamate Antagonists
509
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
509